Browsing publications by Professor Ruth Plummer

Newcastle AuthorsTitleYearFull text
Professor Ruth Plummer
A Multicenter Phase I Study of Pazopanib in Combination with Paclitaxel in First-Line Treatment of Patients with Advanced Solid Tumors2015
Professor Ruth Plummer
DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma2014
Professor Ruth Plummer
Dose-Response Relationship in Phase I Clinical Trials: A European Drug Development Network (EDDN) Collaboration Study2014
Professor Alan Calvert
Professor Ruth Plummer
Effect of erlotinib on CYP3A activity, evaluated in vitro and by dual probes in patients with cancer2014
Professor Ruth Plummer
First-in-human phase 1 study of MLN2480, an investigational oral pan-RAF kinase inhibitor, in patients (pts) with relapsed or refractory solid tumors, including BRAF/NRAS-mutant melanoma2014
Professor Ruth Plummer
Interim analysis of STEVIE, a single-arm, open-label, multicentre study to evaluate the safety of the hedgehog pathway inhibitor vismodegib in patients with advanced basal cell carcinoma2014
Dr Neil Rajan
Dr Piotr Pieniazek
Paul Hainsworth
Dr Fiona Douglas
Professor Ruth Plummer
et al.
Mesenteric cysts in Gorlin syndrome: a mimic of metastatic disease2014
Professor Ruth Plummer
Poly(ADP-ribose)polymerase (PARP) Inhibitors: From Bench to Bedside2014
Ashleigh McConnell
Dr Ellis Ellis
Dr Graeme O'Boyle
Professor Ruth Plummer
Dr Stamatina Verykiou
et al.
Prognostic significance of CXCR4 expression in cutaneous melanoma2014
James Murray
Huw Thomas
Philip Berry
Suzanne Kyle
Dr Miranda Patterson
et al.
Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules2014
1234567891011